Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study

BackgroundVenous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a major cause of morbidity and mortality in patients with obesity. Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been associated with weight loss and potential r...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-05-01
Edice:	Frontiers in Medicine
Témata:	deep vein thrombosis glucagon-like peptide-1 receptor agonists obesity pulmonary embolism tirzepatide venous thromboembolism
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1820366/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!